Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)

被引：2
|
作者：
Weeks, JC
Romanus, D
Herndon, JE
Schrag, D
Mayer, RJ
Kemeny, N
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] CALGB Stat Ctr, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67251-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of colorectal cancer screening
    Heresbach, D
    Manfrédi, S
    Branger, B
    Bretagne, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (01): : 44 - 58
  • [22] Cost-effectiveness of colorectal Cancer Screening
    Sailer, M.
    COLOPROCTOLOGY, 2012, 34 (06) : 441 - 442
  • [23] Cost-effectiveness of cetuximab for colorectal cancer
    Park, Taehwan
    Choi, Chang-ju
    Choi, Yeera
    Suh, Dong-Churl
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 667 - 677
  • [24] Cost-effectiveness of colorectal cancer screening
    Glick, SN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (04): : 407 - 408
  • [25] The cost-effectiveness of screening for colorectal cancer
    Telford, Jennifer J.
    Levy, Adrian R.
    Sambrook, Jennifer C.
    Zou, Denise
    Enns, Robert A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (12) : 1307 - 1313
  • [26] Cost-effectiveness of colorectal cancer screening
    McMahon, PM
    Bosch, JL
    Gleason, S
    Halpern, EF
    Lester, JS
    Gazelle, GS
    RADIOLOGY, 2001, 219 (01) : 44 - 50
  • [27] Cost-effectiveness in the prevention of colorectal cancer
    Sonnenberg, A
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (04) : 1069 - +
  • [28] Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal Cancer
    Patel, Kishan K.
    Stein, Stacey
    Lacy, Jill
    O'Hara, Mark
    Huntington, Scott F.
    JAMA NETWORK OPEN, 2021, 4 (01) : E2033441
  • [29] Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer
    Huang, Zijia
    Zhou, Lingyan
    Zheng, Hanrui
    Zhan, Mei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (04) : 872 - 880
  • [30] Measuring the cost-effectiveness (CE) of therapies treating metastatic colorectal cancer (mCRC).
    Lakdawalla, D.
    Penrod, J.
    Maclean, R.
    Humphrey, J. S.
    Seabury, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345